Prostate cancer: Gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation

Radiology

Volumn 232, Issue 3, 2004, Pages 830-833

  Donnelly, Sarah E ^a   Donnelly, Bryan J ^a   Saliken, John C ^a   Raber, Earl L ^a   Vellet, A Dale ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cryotherapy; Prostate neoplasms, MR; Prostate neoplasms, therapy; Prostate, biopsy

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

AGED; BIOPSY, NEEDLE; CRYOSURGERY; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 4143049005     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2323030841     Document Type: Article

References (14)

1. O'Dowd GJ, Veltri RW, Orozco R, Miller MC, Oesterling JE. Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J Urol 1997; 158: 687-698.
2. Kindrick AV, Grossfeld GD, Stier DM, Flanders SC, Henning JM, Carroll PR. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database. J Urol 1998; 160: 2102-2106.
3. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55:99-109.
4. Parivar F, Hricak H, Shinohara K, et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 1996; 48:594-599.
5. Kalbhen CL, Hricak H, Shinohara K, et al. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology 1996; 198: 807-811.
6. Hawighorst H, Dorsam J, Knopp MV, et al. MR tomographic monitoring of prostate carcinoma after cryotherapy: initial results. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 168:44-48.
7. 3) spatial resolution. Radiology 1996; 198:795-805.
8. D'Amico AV, Schnall M, Whittington R, et al. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 1998; 51: 449-454.
9. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999; 213: 481-488.
10. Vellet AD, Saliken J, Donnelly B, et al. Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications. Radiology 1997; 203:653-659.
11. Zhu L, Xu LX. Evaluation of the effectiveness of transurethral radio frequency hyperthermia in the canine prostate: temperature distribution analysis. J Biomech Eng 1999; 121:584-590.
12. Yuan DY, Valvano JW, Anderson GT. Measurement of thermal conductivity, thermal diffusivity, and perfusion. Biomed Sci Instrum 1993; 29:435-442.
13. Cooper TE, Trezek GJ. Correlation of thermal properties of some human tissue with water content. Aerosp Med 1971; 42:24-27.
14. Chato JC. Measurement of thermal properties of growing tumors. Ann N Y Acad Sci 1980; 335:67-85.